Hormone therapy (HT) continues to be the most effective treatment for menopause symptoms such as vasomotor symptoms and urogenital atrophy, according to updated guidelines on managing women's overall midlife health from the International Menopause Society.
Because the risk–benefit ratio differs for perimenopausal women compared with older, postmenopausal women, "[Menopausal HT (MHT)] must be individualized and tailored according to symptoms and the need for prevention, as well as personal and family history, results of relevant investigations, the woman's preferences and expectations," write Rodney J. Baber, MD, from the University of Sydney in Australia, and colleagues from the International Menopause Society Writing Group.
"Consideration of MHT should be part of an overall strategy including lifestyle recommendations regarding diet, exercise, smoking cessation and safe levels of alcohol consumption for maintaining the health of peri- and postmenopausal women," the authors write.
The recommendations appeared in Climacteric, along with a revised consensus statement on HT. Various major menopause and endocrine medical societies, including the North American Menopause Society and the Endocrine Society, endorse the consensus statement.